drugset / Trial / NCT01115049

Hexetidine and Chlorobutanol for Lesions Due to Prostheses

NCT01115049

Phase 4 Completed 44 enrolled Federico II University
RandomizedParallel-groupTriple-blindSupportive care

Summary

Objectives: The study aimed at assessing the efficacy of a new mouthwash in treating oral lesions due to removable prostheses. Methods: The present prospective randomized clinical trial was performed on 44 patients. The experimentation lasted for 4 weeks and 4 operators participated. The effects of the mouthwash were evaluated subjectively and objectively, with questionnaires, Visual Analogic Scales and clinical examinations. The results were statistically analyzed. The following variables were recorded: presence of mucosal lesions due to incongruous removable prostheses and lasting of pain after rinsing.

Timeline

Start
2010-02
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Chlorhexidine Small molecule 0.2 %
Subject chlorobutanol Small molecule 0.5 %
Subject hexetidine Small molecule 0.1 %

Indications